RS82003A - Anthranilic acid amides, method for the production thereof, their use as antiarhythmia agents, and pharmaceutical preparations thereof - Google Patents
Anthranilic acid amides, method for the production thereof, their use as antiarhythmia agents, and pharmaceutical preparations thereofInfo
- Publication number
- RS82003A RS82003A YUP-820/03A YUP82003A RS82003A RS 82003 A RS82003 A RS 82003A YU P82003 A YUP82003 A YU P82003A RS 82003 A RS82003 A RS 82003A
- Authority
- RS
- Serbia
- Prior art keywords
- acid amides
- anthranilic acid
- production
- pharmaceutical preparations
- antiarhythmia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Furan Compounds (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to anthranilic acid amides, to a method for the production thereof, to their use as a medicament, and to pharmaceutical preparations containing these anthranilic acid amides. The anthranilic acid amides consist of compounds of formula (I) in which R(1) to (R7) have the meanings as cited in the claims, act upon the Kv1.5 potassium channel, and inhibit a potassium stream described as an "ultra-rapidly activating delayed rectifier" in the human cardiac atrium. The compounds are therefore especially suited as novel antiarrhythmic active substances, particularly for treating and preventing atrial arrhythmias, e.g. atrial fibrillation AF or atrial flutter.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10121003A DE10121003A1 (en) | 2001-04-28 | 2001-04-28 | Anthranilic acid amides, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them |
PCT/EP2002/004138 WO2002088073A1 (en) | 2001-04-28 | 2002-04-13 | Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
RS82003A true RS82003A (en) | 2007-02-05 |
Family
ID=7683152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-820/03A RS82003A (en) | 2001-04-28 | 2002-04-13 | Anthranilic acid amides, method for the production thereof, their use as antiarhythmia agents, and pharmaceutical preparations thereof |
Country Status (36)
Country | Link |
---|---|
US (2) | US7235690B2 (en) |
EP (1) | EP1385820B1 (en) |
JP (1) | JP4231295B2 (en) |
KR (1) | KR100865250B1 (en) |
CN (1) | CN100522937C (en) |
AR (1) | AR033623A1 (en) |
AT (1) | ATE528288T1 (en) |
AU (1) | AU2002338494B2 (en) |
BG (1) | BG108215A (en) |
BR (1) | BR0209185A (en) |
CA (1) | CA2445341C (en) |
CR (1) | CR7099A (en) |
CZ (1) | CZ20032921A3 (en) |
DE (1) | DE10121003A1 (en) |
EC (1) | ECSP034780A (en) |
EE (1) | EE05267B1 (en) |
HK (1) | HK1064663A1 (en) |
HR (1) | HRP20030871A2 (en) |
HU (1) | HUP0304043A3 (en) |
IL (2) | IL158504A0 (en) |
MA (1) | MA27002A1 (en) |
MX (1) | MXPA03008419A (en) |
MY (1) | MY143521A (en) |
NO (1) | NO328872B1 (en) |
NZ (1) | NZ529129A (en) |
OA (1) | OA12598A (en) |
PE (1) | PE20021088A1 (en) |
PL (1) | PL363433A1 (en) |
RS (1) | RS82003A (en) |
RU (1) | RU2283833C2 (en) |
SK (1) | SK13262003A3 (en) |
TN (1) | TNSN03084A1 (en) |
TW (1) | TWI259833B (en) |
UA (1) | UA76986C2 (en) |
WO (1) | WO2002088073A1 (en) |
ZA (1) | ZA200306991B (en) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7119120B2 (en) * | 2001-12-26 | 2006-10-10 | Genzyme Corporation | Phosphate transport inhibitors |
US7119112B2 (en) * | 2002-02-28 | 2006-10-10 | Icagen, Inc. | Sulfonamides as potassium channel blockers |
BR0309522A (en) * | 2002-04-26 | 2005-02-09 | Ishihara Sangyo Kaisha | Pyridine compounds or salts thereof and herbicides containing them |
DE10312073A1 (en) * | 2003-03-18 | 2004-09-30 | Aventis Pharma Deutschland Gmbh | 2- (Butyl-1-sulfonylamino) -N- [1 (R) - (6-methoxypyridin-3yl) -propyl] -benzamide, its use as a medicament and pharmaceutical compositions containing the same |
DE10312061A1 (en) * | 2003-03-18 | 2004-09-30 | Aventis Pharma Deutschland Gmbh | Combination of phenylcarboxamides with blockers of the IK channel and their use for the treatment of atrial arrhythmias |
US20040192738A1 (en) * | 2003-03-18 | 2004-09-30 | Aventis Pharma Deutschland Gmbh | 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it |
GB0315950D0 (en) | 2003-06-11 | 2003-08-13 | Xention Discovery Ltd | Compounds |
MXPA06001550A (en) | 2003-08-08 | 2006-09-04 | Johnson & Johnson | 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators. |
DE10341233A1 (en) * | 2003-09-08 | 2005-03-24 | Aventis Pharma Deutschland Gmbh | Composition, useful to treat e.g. atrial fibrillation, atrial flutter and atrial arrhythmia, comprises at least one beta-blocker and at least one compound of a phenylcarboxylic acid amide derivative |
DE102004009931A1 (en) * | 2004-02-26 | 2005-09-15 | Aventis Pharma Deutschland Gmbh | Use of specific 2-substituted benzamides for treating and preventing cardiac insufficiency, especially where caused by diastolic dysfunction, act by inhibition of the Kv1.5 potassium channel |
GB0412986D0 (en) | 2004-06-10 | 2004-07-14 | Xention Discovery Ltd | Compounds |
CN101061116A (en) * | 2004-09-24 | 2007-10-24 | 詹森药业有限公司 | Sulfonamide compounds |
US7576212B2 (en) | 2004-12-09 | 2009-08-18 | Xention Limited | Thieno[2,3-B] pyridines as potassium channel inhibitors |
GB0525164D0 (en) | 2005-12-09 | 2006-01-18 | Xention Discovery Ltd | Compounds |
GB0526252D0 (en) * | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
GB2434794A (en) * | 2006-02-03 | 2007-08-08 | Prom Ltd | Continuous process for forming anthranilic acid and treatment of waste water containing organic material |
US7678818B2 (en) * | 2006-02-07 | 2010-03-16 | Hoffmann-La Roche Inc. | Anthranilamide and 2-amino-heteroarene-carboxamide compounds |
CN101636154B (en) * | 2006-04-27 | 2011-12-14 | 塞诺菲-安万特德国有限公司 | Inhibitors of the TASK-1 and TASK-3 ion channels |
MX2011000051A (en) * | 2008-07-07 | 2011-07-28 | Fasgen Inc | Novel compounds, pharmaceutical compositions containing same, methods of use for same, and methods for preparing same. |
GB0815781D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
GB0815784D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
GB201105659D0 (en) | 2011-04-01 | 2011-05-18 | Xention Ltd | Compounds |
MX2013015058A (en) | 2011-06-24 | 2014-01-20 | Amgen Inc | Trpm8 antagonists and their use in treatments. |
CN103906733A (en) | 2011-06-24 | 2014-07-02 | 安姆根有限公司 | TRMP8 antagonists and their use in treatments |
NO3175985T3 (en) | 2011-07-01 | 2018-04-28 | ||
NZ627942A (en) | 2012-01-27 | 2016-03-31 | Gilead Sciences Inc | Combination therapies using late sodium ion channel blockers and potassium ion channel blockers |
US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
CN103130696B (en) * | 2013-03-21 | 2014-06-11 | 山东大学 | Anthranilamide compound as well as preparation method and application thereof |
DK3186242T3 (en) | 2014-08-29 | 2021-12-20 | Tes Pharma S R L | ALFA-AMINO-BETA-CARBOXYMUCONSIDE-SEMIALDEHYDE-DECARBOXYLASE INHIBITORS |
KR101893836B1 (en) | 2016-07-11 | 2018-08-31 | 김종해 | System and method for making vegetable alternative milk. |
BR112021006225A2 (en) | 2018-10-02 | 2021-07-06 | Syngenta Participations Ag | pesticide-active benzene- and azine-amide compounds |
CN111285806B (en) * | 2018-12-06 | 2022-04-15 | 中国医学科学院药物研究所 | Pyrazole compound and preparation method, application and pharmaceutical composition thereof |
UY38623A (en) | 2019-03-29 | 2020-10-30 | Syngenta Crop Protection Ag | DIAZINE-AMIDE COMPOUNDS ACTIVE AS PESTICIDES |
WO2020201398A1 (en) | 2019-04-05 | 2020-10-08 | Syngenta Crop Protection Ag | Pesticidally active diazine-amide compounds |
US20220169629A1 (en) | 2019-04-11 | 2022-06-02 | Syngenta Crop Protection Ag | Pesticidally active diazine-amide compounds |
EP4017851A1 (en) | 2019-08-23 | 2022-06-29 | Syngenta Crop Protection AG | Pesticidally active pyrazine-amide compounds |
CN114630825A (en) | 2019-11-01 | 2022-06-14 | 先正达农作物保护股份公司 | Pesticidally active fused bicyclic heteroaromatic compounds |
WO2021151926A1 (en) | 2020-01-30 | 2021-08-05 | Syngenta Crop Protection Ag | Pesticidally active fused bicyclic heteroaromatic amino compounds |
CN115244036A (en) | 2020-02-27 | 2022-10-25 | 先正达农作物保护股份公司 | Pesticidally active diazine-bisamide compounds |
WO2022101265A1 (en) | 2020-11-13 | 2022-05-19 | Syngenta Crop Protection Ag | Pesticidally active fused bicyclic heteroaromatic compounds |
WO2022258481A1 (en) | 2021-06-09 | 2022-12-15 | Syngenta Crop Protection Ag | Pesticidally active diazine-amide compounds |
AU2022299145A1 (en) | 2021-06-24 | 2023-12-07 | Syngenta Crop Protection Ag | 2-[3-[1 [(quinazolin-4-yl)amino]ethyl]pyrazin-2-yl]thiazole-5-carbonitrile derivatives and similar compounds as pesticides |
EP4377312A1 (en) | 2021-07-29 | 2024-06-05 | Syngenta Crop Protection AG | Pesticidally active fused bicyclic heteroaromatic compounds |
WO2023072849A1 (en) | 2021-10-27 | 2023-05-04 | Syngenta Crop Protection Ag | Pesticidally active pyridazinone compounds |
WO2023104714A1 (en) | 2021-12-10 | 2023-06-15 | Syngenta Crop Protection Ag | Pesticidally active pyridazinone compounds |
WO2023247360A1 (en) | 2022-06-21 | 2023-12-28 | Syngenta Crop Protection Ag | Pesticidally active fused bicyclic heteroaromatic compounds |
WO2024110554A1 (en) | 2022-11-23 | 2024-05-30 | Syngenta Crop Protection Ag | N-[(1 -[2-[6-(pyridazin-3-yl]-1,2,4-triazol-3-yl]ethyl]-quinazolin-4-amine and n-[1-[3-(6-(pyridazin-3-yl)pyrazin-2-yl]ethyl]-8-quinazolin-4-amine derivatives as pesticides |
WO2024133551A1 (en) | 2022-12-21 | 2024-06-27 | Syngenta Crop Protection Ag | Pesticidally active pyridazine compounds |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3497529A (en) | 1967-03-23 | 1970-02-24 | Sandoz Ag | Benzamides |
PT77219B (en) * | 1982-08-24 | 1986-02-04 | May & Baker Ltd | PROCESS FOR THE PREPARATION OF BENZAMIDE DERIVATIVES |
DE4035961A1 (en) | 1990-11-02 | 1992-05-07 | Thomae Gmbh Dr K | CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
CA2057324A1 (en) | 1990-12-18 | 1992-06-19 | Lora Louise Fitch | Benzamide and sulfonamide hypoglycemic agents |
DE4127404A1 (en) | 1991-08-19 | 1993-02-25 | Thomae Gmbh Dr K | CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
DE4236045A1 (en) | 1992-04-03 | 1993-11-04 | Teves Gmbh Alfred | HYDRAULIC CHANGEOVER VALVE FOR A VEHICLE BRAKE SYSTEM |
NO922913L (en) | 1992-07-22 | 1994-07-22 | Iver Hansen | Quick-spotted tires |
WO1994015913A1 (en) | 1992-12-30 | 1994-07-21 | Smithkline Beecham Corporation | Chemical compounds |
JP2861743B2 (en) * | 1993-07-16 | 1999-02-24 | 住友電装株式会社 | Connector terminal joint structure |
HUT74450A (en) | 1993-12-27 | 1996-12-30 | Eisai Co Ltd | Anthranilic acid derivative and pharmaceutical compns. contg. such compds. |
US5436229A (en) | 1994-03-04 | 1995-07-25 | Eli Lilly And Company | Bisulfite adducts of arginine aldehydes |
US5447819A (en) | 1994-05-27 | 1995-09-05 | Eastman Kodak Company | Photographic element containing high dye-yield couplers having improved reactivity |
US5670504A (en) | 1995-02-23 | 1997-09-23 | Merck & Co. Inc. | 2,6-diaryl pyridazinones with immunosuppressant activity |
US5638980A (en) * | 1995-09-29 | 1997-06-17 | Parks; Joseph R. | Fluid storage safety device |
US6083986A (en) | 1996-07-26 | 2000-07-04 | Icagen, Inc. | Potassium channel inhibitors |
US5935945A (en) | 1996-10-31 | 1999-08-10 | Merck & Co., Inc. | Methods of treating or preventing cardiac arrhythmia |
US5969017A (en) | 1996-10-31 | 1999-10-19 | Merck & Co., Inc. | Methods of treating or preventing cardiac arrhythmia |
TW523506B (en) | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
EP1026160A4 (en) | 1997-09-16 | 2003-01-22 | Takeda Chemical Industries Ltd | Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs |
US6140351A (en) | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
CA2315070A1 (en) | 1997-12-17 | 1999-07-01 | Schering Aktiengesellschaft | Ortho-anthranilamide derivatives as anti-coagulants |
US6333337B1 (en) | 1998-01-27 | 2001-12-25 | Icagen, Inc. | Potassium channel inhibitors |
EP1082315A1 (en) | 1998-06-05 | 2001-03-14 | Icagen, Inc. | Potassium channel inhibitors |
DE19837211A1 (en) | 1998-08-17 | 2000-02-24 | Basf Ag | Production of alkyne diol involves reaction of ketone with acetylenic compound and potassium alcoholate in a stoichiometric ratio selected to give gel like adducts with a spherical surface |
AU754204B2 (en) | 1998-09-01 | 2002-11-07 | Bristol-Myers Squibb Company | Potassium channel inhibitors and method |
AU4431400A (en) | 1999-05-12 | 2000-12-05 | Japan As Represented By President Of National Cancer Center | Anticancer agents containing ep1 antagonists as the active ingredient |
WO2000071508A2 (en) | 1999-05-24 | 2000-11-30 | Cor Therapeutics, Inc. | INHIBITORS OF FACTOR Xa |
JP2003500382A (en) | 1999-05-24 | 2003-01-07 | シーオーアール セラピューティクス インコーポレイテッド | Factor Xa inhibitors |
KR20020022716A (en) * | 1999-06-24 | 2002-03-27 | 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 | Macrophage Scavenger Receptor Antagonists |
DE19929076A1 (en) | 1999-06-25 | 2000-12-28 | Aventis Pharma Gmbh | New indanyl-substituted benzenesulfonamide derivatives, as potassium channel blockers useful as safe antiarrhythmic agents, e.g. for treating atrial fibrillation or flutter |
DE19943635A1 (en) | 1999-09-13 | 2001-03-15 | Bayer Ag | Novel aminodicarboxylic acid derivatives with pharmaceutical properties |
US6360221B1 (en) * | 1999-09-21 | 2002-03-19 | Neostar, Inc. | Method and apparatus for the production, delivery, and receipt of enhanced e-mail |
DE19947457A1 (en) | 1999-10-02 | 2001-04-05 | Aventis Pharma Gmbh | New 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter |
FR2800074B1 (en) | 1999-10-22 | 2001-12-21 | Aventis Pharma Sa | NOVEL OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
WO2001035951A2 (en) | 1999-11-18 | 2001-05-25 | Centaur Pharmaceuticals, Inc. | Aryl nitrone therapeutics and methods for treating inflammatory bowel disease |
DE10027151A1 (en) | 2000-05-31 | 2001-12-06 | Bayer Ag | Herbicides based on substituted carboxamides |
EP1339668A2 (en) | 2000-11-28 | 2003-09-03 | Guilford Pharmaceuticals Inc. | Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
US6498184B2 (en) | 2000-12-05 | 2002-12-24 | Akzo Nobel N.V. | Serotonergic compound for a method of treatment of hot flushes in post-menopausal women |
AU2002223958A1 (en) | 2000-12-20 | 2002-07-01 | Warner-Lambert Company Llc | Non-halogenated phenoxy and/or benzyloxy phenols and antimicrobial compositions containing them |
EP1369129A4 (en) | 2001-03-14 | 2005-08-03 | Ono Pharmaceutical Co | Remedies for depression containing ep1 antagonist as the active ingredient |
-
2001
- 2001-04-28 DE DE10121003A patent/DE10121003A1/en not_active Withdrawn
-
2002
- 2002-04-13 CA CA2445341A patent/CA2445341C/en not_active Expired - Fee Related
- 2002-04-13 SK SK1326-2003A patent/SK13262003A3/en unknown
- 2002-04-13 NZ NZ529129A patent/NZ529129A/en unknown
- 2002-04-13 BR BR0209185-2A patent/BR0209185A/en not_active IP Right Cessation
- 2002-04-13 EP EP02742898A patent/EP1385820B1/en not_active Expired - Lifetime
- 2002-04-13 JP JP2002585377A patent/JP4231295B2/en not_active Expired - Fee Related
- 2002-04-13 AU AU2002338494A patent/AU2002338494B2/en not_active Ceased
- 2002-04-13 EE EEP200300529A patent/EE05267B1/en not_active IP Right Cessation
- 2002-04-13 OA OA1200300278A patent/OA12598A/en unknown
- 2002-04-13 CN CNB028082737A patent/CN100522937C/en not_active Expired - Fee Related
- 2002-04-13 RU RU2003134544/04A patent/RU2283833C2/en not_active IP Right Cessation
- 2002-04-13 MX MXPA03008419A patent/MXPA03008419A/en active IP Right Grant
- 2002-04-13 CZ CZ20032921A patent/CZ20032921A3/en unknown
- 2002-04-13 IL IL15850402A patent/IL158504A0/en unknown
- 2002-04-13 WO PCT/EP2002/004138 patent/WO2002088073A1/en active IP Right Grant
- 2002-04-13 PL PL02363433A patent/PL363433A1/en not_active IP Right Cessation
- 2002-04-13 KR KR1020037014122A patent/KR100865250B1/en not_active IP Right Cessation
- 2002-04-13 RS YUP-820/03A patent/RS82003A/en unknown
- 2002-04-13 AT AT02742898T patent/ATE528288T1/en active
- 2002-04-13 UA UA20031110763A patent/UA76986C2/en unknown
- 2002-04-13 HU HU0304043A patent/HUP0304043A3/en unknown
- 2002-04-25 TW TW091108496A patent/TWI259833B/en not_active IP Right Cessation
- 2002-04-25 AR ARP020101502A patent/AR033623A1/en unknown
- 2002-04-26 PE PE2002000354A patent/PE20021088A1/en not_active Application Discontinuation
- 2002-04-26 MY MYPI20021528A patent/MY143521A/en unknown
- 2002-04-26 US US10/132,163 patent/US7235690B2/en not_active Expired - Lifetime
-
2003
- 2003-03-26 EC EC2003004780A patent/ECSP034780A/en unknown
- 2003-07-08 TN TNPCT/EP2002/004138A patent/TNSN03084A1/en unknown
- 2003-09-08 ZA ZA200306991A patent/ZA200306991B/en unknown
- 2003-09-16 MA MA27313A patent/MA27002A1/en unknown
- 2003-09-30 BG BG108215A patent/BG108215A/en unknown
- 2003-10-07 CR CR7099A patent/CR7099A/en unknown
- 2003-10-20 IL IL158504A patent/IL158504A/en not_active IP Right Cessation
- 2003-10-23 NO NO20034751A patent/NO328872B1/en not_active IP Right Cessation
- 2003-10-27 HR HR20030871A patent/HRP20030871A2/en not_active Application Discontinuation
-
2004
- 2004-09-23 HK HK04107327.5A patent/HK1064663A1/en not_active IP Right Cessation
-
2006
- 2006-11-09 US US11/558,132 patent/US7332608B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS82003A (en) | Anthranilic acid amides, method for the production thereof, their use as antiarhythmia agents, and pharmaceutical preparations thereof | |
TWI256950B (en) | Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament and pharmaceutical formulations containing them | |
TNSN03134A1 (en) | Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds | |
HK1066539A1 (en) | Ortho-substituted nitrogen-containing bisaryl compounds use as potassium channel inhibitors | |
YU42503A (en) | Arylated furane and thiophene carboxylic acid amides with potassium channel blocking effect | |
YU24402A (en) | 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicamt and pharmaceutical preparations containing said compounds | |
NO20003233L (en) | 4-hydroxyquinoline-3-carboxamides and hydrazides as antivirals | |
MY133647A (en) | Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates | |
DE60132606D1 (en) | ISOCHINOLINONE AS CALIUM CHANNEL INHIBITORS | |
GB0225475D0 (en) | Therapeutic agents | |
BR0210028A (en) | Antibacterial agents | |
DK0934309T3 (en) | Novel pyridylalkanoic acid amides as cytostatic and immunosuppressive agents | |
DE69912930D1 (en) | NEW SALT FORMS OF (2E) -5-AMINO-5-METHYLHEX-2-ENOLIC ACID N-METHYL-N - ((1R) -1- (METHYLCARBAMOYL) -2-PHRUYLRTHYL) CARBAMOYL) -2- (2-NAPHTYL) ETHYL ) AMID | |
GR3036184T3 (en) | Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof | |
HK1120794A1 (en) | Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them | |
WO2003087062A3 (en) | 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation | |
HRP20050815A2 (en) | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound | |
MXPA02008213A (en) | Substituted piperazine compounds. | |
BR0014751A (en) | Compound, stereoisomer or mixture of stereoisomers, pharmaceutical composition, method of treating a patient in need of antimicrobial treatment, and use of a compound | |
DE60208541D1 (en) | ANTIBACTERIAL AGENTS |